Tootfinder

Opt-in global Mastodon full text search. Join the index!

No exact results. Similar results found.
@arXiv_csLG_bot@mastoxiv.page
2024-03-28 06:51:47

Aiming for Relevance
Bar Eini Porat, Danny Eytan, Uri Shalit
arxiv.org/abs/2403.18668 arxiv.org/pdf/2403.18668

@arXiv_csCR_bot@mastoxiv.page
2024-01-29 08:00:04

This arxiv.org/abs/2201.11291 has been replaced.
link: scholar.google.com/scholar?q=a

@arXiv_eessIV_bot@mastoxiv.page
2024-04-29 08:33:58

This arxiv.org/abs/2211.16879 has been replaced.
link: scholar.google.com/scholar?q=a

@arXiv_csLG_bot@mastoxiv.page
2024-03-28 06:51:04

Multi-Modal Contrastive Learning for Online Clinical Time-Series Applications
Fabian Baldenweg, Manuel Burger, Gunnar R\"atsch, Rita Kuznetsova
arxiv.org/abs/2403.18316

@arXiv_csHC_bot@mastoxiv.page
2024-02-23 07:12:38

Multimodal Healthcare AI: Identifying and Designing Clinically Relevant Vision-Language Applications for Radiology
Nur Yildirim, Hannah Richardson, Maria T. Wetscherek, Junaid Bajwa, Joseph Jacob, Mark A. Pinnock, Stephen Harris, Daniel Coelho de Castro, Shruthi Bannur, Stephanie L. Hyland, Pratik Ghosh, Mercy Ranjit, Kenza Bouzid, Anton Schwaighofer, Fernando P\'erez-Garc\'ia, Harshita Sharma, Ozan Oktay, Matthew Lungren, Javier Alvarez-Valle, Aditya Nori, Anja Thieme

@arXiv_eessIV_bot@mastoxiv.page
2024-02-27 08:24:49

This arxiv.org/abs/2211.09887 has been replaced.
link: scholar.google.com/scholar?q=a

@arXiv_csPL_bot@mastoxiv.page
2024-02-14 07:30:38

An Executable Specification of Oncology Dose-Escalation Protocols with Prolog
David C. Norris, Markus Triska
arxiv.org/abs/2402.08334

@arXiv_qbioQM_bot@mastoxiv.page
2024-03-25 08:46:53

This arxiv.org/abs/2403.10581 has been replaced.
initial toot: mastoxiv.page/@arXiv_qbi…

@arXiv_eessIV_bot@mastoxiv.page
2024-02-20 08:32:33

This arxiv.org/abs/2402.08987 has been replaced.
initial toot: mastoxiv.page/@arXiv_ees…

@arXiv_eessIV_bot@mastoxiv.page
2024-02-15 07:20:28

Multi-modality transrectal ultrasound vudei classification for identification of clinically significant prostate cancer
Hong Wu, Juan Fu, Hongsheng Ye, Yuming Zhong, Xuebin Zhou, Jianhua Zhou, Yi Wang
arxiv.org/abs/2402.08987